Henry Schein Q4 Earnings Miss Expectations, Restructures for Growth

Henry Schein, the world's largest provider of health care solutions to office-based dental and medical practitioners, reported its fourth-quarter and full-year 2024 financial results on February 25, 2025. While the company's earnings and revenue missed analysts' expectations, Henry Schein is restructuring its business to drive growth and maintain its competitive edge.



Henry Schein reported a fourth-quarter GAAP diluted EPS of $0.74 and non-GAAP diluted EPS of $1.19, falling short of the analyst estimate of $1.21. Total net sales for the quarter were $3.19 billion, an increase of 5.8% compared to the fourth quarter of 2023, but still below the consensus estimate of $3.30 billion. The company attributed the miss to slower-than-anticipated recovery from a cyber incident and restructuring costs.

To address these challenges and accelerate growth, Henry Schein announced a new organizational structure and appointed Andrea Albertini and Tom Popeck to lead its three business groups: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. The company is also simplifying its organizational structure to improve decision-making and reduce costs.